Total Funding
61
84
Total FundingSeries B raised
Growth Score 61 in past quarter
-3 pts
Heat Score 84 in past quarter
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
83402
ProAbTech is a biotech company developing bioconjugation technology to enhance proteins and antibody-based drug development platforms.
- Cho Jeong-haeng: CEO
About the Company
ProAbTech develops biotechnology solutions focused on site-specific bioconjugation technology for therapeutic proteins and antibodies. Its platform enhances the precision, stability, and functionality of biologic drugs. The company works on advanced drug development solutions aimed at improving targeted therapies and supporting innovation in
protein-based pharmaceuticals and medical research applications.